Header Logo

Connection

MIGUEL A RODRIGUEZ-BIGAS to Neoplasm Staging

Back to Details
This is a "connection" page, showing publications MIGUEL A RODRIGUEZ-BIGAS has written about Neoplasm Staging.
MIGUEL A RODRIGUEZ-BIGAS
Connection Strength
0.628
Neoplasm Staging
  1. Who Should Get Lateral Pelvic Lymph Node Dissection After Neoadjuvant Chemoradiation? Dis Colon Rectum. 2019 10; 62(10):1158-1166.
    View in: PubMed
    Score: 0.057
  2. Intraoperative radiation therapy for locally advanced primary and recurrent colorectal cancer: ten-year institutional experience. J Surg Oncol. 2014 Jun; 109(7):652-8.
    View in: PubMed
    Score: 0.039
  3. Morbidity of staged proctectomy after hepatectomy for colorectal cancer: a matched case-control analysis. Ann Surg Oncol. 2013 Feb; 20(2):482-90.
    View in: PubMed
    Score: 0.035
  4. Practical application of a calculator for conditional survival in colon cancer. J Clin Oncol. 2009 Dec 10; 27(35):5938-43.
    View in: PubMed
    Score: 0.028
  5. A twenty-year experience with adenocarcinoma of the anal canal. Dis Colon Rectum. 2009 Aug; 52(8):1375-80.
    View in: PubMed
    Score: 0.028
  6. Phase II trial of neoadjuvant bevacizumab, capecitabine, and radiotherapy for locally advanced rectal cancer. Int J Radiat Oncol Biol Phys. 2010 Mar 01; 76(3):824-30.
    View in: PubMed
    Score: 0.028
  7. Are we undertreating rectal cancer in the elderly? An epidemiologic study. Ann Surg. 2007 Aug; 246(2):215-21.
    View in: PubMed
    Score: 0.025
  8. Pelvic exenteration affords safe and durable treatment for locally advanced rectal carcinoma. Ann Surg Oncol. 2007 Jun; 14(6):1870-7.
    View in: PubMed
    Score: 0.024
  9. Clinical and pathologic predictors of locoregional recurrence, distant metastasis, and overall survival in patients treated with chemoradiation and mesorectal excision for rectal cancer. Am J Clin Oncol. 2006 Jun; 29(3):219-24.
    View in: PubMed
    Score: 0.023
  10. Pathologic evaluation of total mesorectal excision: big brother is watching. J Clin Oncol. 2002 Apr 01; 20(7):1714-5.
    View in: PubMed
    Score: 0.017
  11. Intraoperative Radiation After Pelvic Short Course Radiation-Based Total Neoadjuvant Therapy for Patients With Rectal Adenocarcinoma at High Risk for Local Recurrence. Clin Colorectal Cancer. 2022 09; 21(3):204-211.
    View in: PubMed
    Score: 0.017
  12. Benchmarking Outcomes for Definitive Treatment of Young-Onset, Locally Advanced Rectal Cancer. Clin Colorectal Cancer. 2022 03; 21(1):e28-e37.
    View in: PubMed
    Score: 0.016
  13. Local excision of rectal carcinoma. Am Surg. 2001 Aug; 67(8):774-9.
    View in: PubMed
    Score: 0.016
  14. Detection of Pathogenic Germline Variants Among Patients With Advanced Colorectal Cancer Undergoing Tumor Genomic Profiling for Precision Medicine. Dis Colon Rectum. 2019 04; 62(4):429-437.
    View in: PubMed
    Score: 0.014
  15. Session 4: Shaping radiotherapy for rectal cancer: should this be personalized? Colorectal Dis. 2018 05; 20 Suppl 1:92-96.
    View in: PubMed
    Score: 0.013
  16. Serum exosomal miR-4772-3p is a predictor of tumor recurrence in stage II and III colon cancer. Oncotarget. 2016 Nov 15; 7(46):76250-76260.
    View in: PubMed
    Score: 0.012
  17. Comparative effectiveness of primary tumor resection in patients with stage IV colon cancer. Cancer. 2017 04 01; 123(7):1124-1133.
    View in: PubMed
    Score: 0.011
  18. A proposed staging system and stage-specific interventions for familial adenomatous polyposis. Gastrointest Endosc. 2016 Jul; 84(1):115-125.e4.
    View in: PubMed
    Score: 0.011
  19. Time trend analysis of primary tumor resection for stage IV colorectal cancer: less surgery, improved survival. JAMA Surg. 2015 Mar 01; 150(3):245-51.
    View in: PubMed
    Score: 0.010
  20. Increasing disparities in the age-related incidences of colon and rectal cancers in the United States, 1975-2010. JAMA Surg. 2015 Jan; 150(1):17-22.
    View in: PubMed
    Score: 0.010
  21. Risk-adjusted pathologic margin positivity rate as a quality indicator in rectal cancer surgery. J Clin Oncol. 2014 Sep 20; 32(27):2967-74.
    View in: PubMed
    Score: 0.010
  22. Impact of ileostomy-related complications on the multidisciplinary treatment of rectal cancer. Ann Surg Oncol. 2014 Feb; 21(2):507-12.
    View in: PubMed
    Score: 0.009
  23. An individualized conditional survival calculator for patients with rectal cancer. Dis Colon Rectum. 2013 May; 56(5):551-9.
    View in: PubMed
    Score: 0.009
  24. Metformin use and improved response to therapy in rectal cancer. Cancer Med. 2013 Feb; 2(1):99-107.
    View in: PubMed
    Score: 0.009
  25. Comparative analysis of lymph node metastases in patients with ypT0-2 rectal cancers after neoadjuvant chemoradiotherapy. Dis Colon Rectum. 2013 Feb; 56(2):135-41.
    View in: PubMed
    Score: 0.009
  26. Multimodality salvage of recurrent disease after local excision for rectal cancer. Dis Colon Rectum. 2012 Dec; 55(12):1213-9.
    View in: PubMed
    Score: 0.009
  27. Prognostic significance of anastomotic recurrence from colorectal adenocarcinoma. Dis Colon Rectum. 1992 Sep; 35(9):838-42.
    View in: PubMed
    Score: 0.009
  28. Neoadjuvant treatment response as an early response indicator for patients with rectal cancer. J Clin Oncol. 2012 May 20; 30(15):1770-6.
    View in: PubMed
    Score: 0.008
  29. Clinicopathology and outcomes for mucinous and signet ring colorectal adenocarcinoma: analysis from the National Cancer Data Base. Ann Surg Oncol. 2012 Sep; 19(9):2814-21.
    View in: PubMed
    Score: 0.008
  30. Pretreatment high-resolution rectal MRI and treatment response to neoadjuvant chemoradiation. Dis Colon Rectum. 2012 Apr; 55(4):371-7.
    View in: PubMed
    Score: 0.008
  31. Local excision after preoperative chemoradiation results in an equivalent outcome to total mesorectal excision in selected patients with T3 rectal cancer. Ann Surg Oncol. 2010 Feb; 17(2):441-7.
    View in: PubMed
    Score: 0.007
  32. Recurrent malignant salivary gland neoplasms. J Surg Oncol. 1989 Oct; 42(2):92-5.
    View in: PubMed
    Score: 0.007
  33. Management and outcomes of anorectal infection in the cancer patient. Ann Surg Oncol. 2009 Oct; 16(10):2752-8.
    View in: PubMed
    Score: 0.007
  34. cT3N0 rectal cancer: potential overtreatment with preoperative chemoradiotherapy is warranted. J Clin Oncol. 2008 Jan 20; 26(3):368-73.
    View in: PubMed
    Score: 0.006
  35. Sentinel lymph node evaluation does not improve staging accuracy in colon cancer. Ann Surg Oncol. 2008 Jan; 15(1):46-51.
    View in: PubMed
    Score: 0.006
  36. Predictors of tumor response and downstaging in patients who receive preoperative chemoradiation for rectal cancer. Cancer. 2007 May 01; 109(9):1750-5.
    View in: PubMed
    Score: 0.006
  37. Lymph node evaluation and survival after curative resection of colon cancer: systematic review. J Natl Cancer Inst. 2007 Mar 21; 99(6):433-41.
    View in: PubMed
    Score: 0.006
  38. Phase II study of capecitabine (Xeloda) and concomitant boost radiotherapy in patients with locally advanced rectal cancer. Int J Radiat Oncol Biol Phys. 2006 Nov 01; 66(3):762-71.
    View in: PubMed
    Score: 0.006
  39. Staging intra-abdominal desmoid tumors in familial adenomatous polyposis: a search for a uniform approach to a troubling disease. Dis Colon Rectum. 2005 Aug; 48(8):1528-34.
    View in: PubMed
    Score: 0.005
  40. Transrectal ultrasound versus magnetic resonance imaging for detection of rectal wall invasion by prostate cancer. Prostate. 2005 Jan 01; 62(1):101-4.
    View in: PubMed
    Score: 0.005
  41. Long-term results using local excision after preoperative chemoradiation among selected T3 rectal cancer patients. Int J Radiat Oncol Biol Phys. 2004 Nov 15; 60(4):1098-105.
    View in: PubMed
    Score: 0.005
  42. Is abdominoperineal resection a good option for stage IV adenocarcinoma of the distal rectum? J Surg Oncol. 2002 Sep; 81(1):3-7.
    View in: PubMed
    Score: 0.004
  43. New approach to the substaging of node-positive colorectal adenocarcinoma. Ann Surg Oncol. 1999 Mar; 6(2):161-5.
    View in: PubMed
    Score: 0.003
  44. Survival of patients with hereditary colorectal cancer: comparison of HNPCC and colorectal cancer in FAP patients with sporadic colorectal cancer. Int J Cancer. 1999 Jan 18; 80(2):183-7.
    View in: PubMed
    Score: 0.003
  45. Colorectal carcinoma survival among hereditary nonpolyposis colorectal carcinoma family members. Cancer. 1998 Jul 15; 83(2):259-66.
    View in: PubMed
    Score: 0.003
  46. Intraoperative determinants of unresectability for patients with colorectal hepatic metastases. Cancer. 1998 Apr 01; 82(7):1244-9.
    View in: PubMed
    Score: 0.003
  47. Absence of frequent involvement of modifier of Min(APC) in sporadic colorectal cancer. Ann Surg Oncol. 1998 Mar; 5(2):181-5.
    View in: PubMed
    Score: 0.003
  48. Anal canal and perianal epidermoid cancers. J Am Coll Surg. 1997 Nov; 185(5):494-505.
    View in: PubMed
    Score: 0.003
  49. Genomic instability in sporadic colorectal cancer quantitated by inter-simple sequence repeat PCR analysis. Genes Chromosomes Cancer. 1997 Jan; 18(1):19-29.
    View in: PubMed
    Score: 0.003
  50. Primary signet-ring cell carcinoma of the colon and rectum. Ann Surg Oncol. 1996 Jul; 3(4):344-8.
    View in: PubMed
    Score: 0.003
  51. Wide perineal dissection and its effect on local recurrence following potentially curative abdominoperineal resection for rectal adenocarcinoma. Cancer Invest. 1996; 14(1):1-5.
    View in: PubMed
    Score: 0.003
  52. Curative resection for stage I rectal cancer: natural history, prognostic factors, and recurrence patterns. Cancer Invest. 1996; 14(5):491-7.
    View in: PubMed
    Score: 0.003
  53. Primary colorectal non-Hodgkin's lymphoma. Ann Surg Oncol. 1994 May; 1(3):222-8.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.